Renal Associates P. A. · US
Area of research
Hematology · Nephrology
Research interest
Research interests include Erythropoietin and Anemia Treatment, Dialysis and Renal Disease Management, Hemoglobinopathies and Related Disorders, and Iron Metabolism and Disorders.
Chronic Inflammation as an Overlooked Link between Cardiovascular and Kidney Disease: A Focus on IL-6 and C-Reactive Protein.
A Phase 2 Clinical Trial of Oxylanthanum Carbonate in Patients Receiving Maintenance Hemodialysis with Hyperphosphatemia.
Effect of Avenciguat on Albuminuria in Patients with CKD: Two Randomized Placebo-Controlled Trials.
Effect of Ziltivekimab on Determinants of Hemoglobin in Patients with CKD Stage 3-5: An Analysis of a Randomized Trial (RESCUE).
Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE Study
Selonsertib in Patients with Diabetic Kidney Disease: A Phase 2b Randomized Active Run-In Clinical Trial.
Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE Study.
Pharmacokinetics, Pharmacodynamics, and Safety of Vadadustat in Healthy Volunteers and Patients with Chronic Kidney Disease.
Among Patients Meeting the KDIGO CKD Practice Point Criterion for Treatment of Metabolic Acidosis, Higher Serum Bicarbonate Concentrations Are Associated with Slower CKD Progression
Prospective, randomized, multicenter clinical study comparing a self-expanding covered stent to percutaneous transluminal angioplasty for treatment of upper extremity hemodialysis arteriovenous fistula stenosis
Effect of Ziltivekimab on Determinants of Hemoglobin in Patients with CKD Stage 3–5: An Analysis of a Randomized Trial (RESCUE)
Kidney outcomes with finerenone: an analysis from the FIGARO-DKD study
Effects of Bardoxolone Methyl in Alport Syndrome
Erythropoietic effects of vadadustat in patients with anemia associated with chronic kidney disease
Changes in Iron Availability with Roxadustat in Nondialysis- and Dialysis-Dependent Patients with Anemia of CKD.
Consensus-Based Recommendations for the Management of Hyperkalemia in the Hemodialysis Setting.
Phosphate Frustration: Treatment Options to Complement Current Therapies.
IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial
Vadadustat in Patients with Anemia and Non–Dialysis-Dependent CKD
Safety and Efficacy of Vadadustat for Anemia in Patients Undergoing Dialysis
Study Design and Baseline Characteristics of the CARDINAL Trial: A Phase 3 Study of Bardoxolone Methyl in Patients with Alport Syndrome
Effects of Bardoxolone Methyl on Hepatic Enzymes in Patients with Type 2 Diabetes Mellitus and Stage 4 CKD
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
Sodium Zirconium Cyclosilicate among Individuals with Hyperkalemia
Novel Oral Iron Therapies for Iron Deficiency Anemia in Chronic Kidney Disease
Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney disease
Bardoxolone Methyl Improves Kidney Function in Patients with Chronic Kidney Disease Stage 4 and Type 2 Diabetes: Post-Hoc Analyses from Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes Study
Effects of vadadustat on hemoglobin concentrations in patients receiving hemodialysis previously treated with erythropoiesis-stimulating agents
Effect of ferric citrate on serum phosphate and fibroblast growth factor 23 among patients with nondialysis-dependent chronic kidney disease: path analyses
Effects of bardoxolone methyl on body weight, waist circumference and glycemic control in obese patients with type 2 diabetes mellitus and stage 4 chronic kidney disease